Efficacy and Safety of SAGE-547 Injection in the Treatment of Super-Refractory Status Epilepticus

Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status

Description:

For complete study information, please visit clinicaltrials.gov.

Interested in participating?

We are currently recruiting

IRB Study ID:

151016

Lead Investigator

James Besunder, DO

Director, Pediatric Critical Care; Pediatric Intensivist
Pediatric Critical Care Medicine (PICU)

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...

Search our Site

Need Help?

Operator

Ask Children's

For Family & Patients

I am a...

Quicklinks

Find-A-Provider

Find-A-Location

Services

Health Info

About Us

Research

Search our site:

Efficacy and Safety of SAGE-547 Injection in the Treatment of Super-Refractory Status Epilepticus

Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status

Starting Locations:

Legal:

About Akron Children's